
COVID-19 public health emergency ends, but research, lessons go on
Researchers from the University of Michigan School of Public Health discuss the end of the COVID-19 Public Health Emergency.
We're still accepting applications for fall 2025!
Apply TodayResearchers from the University of Michigan School of Public Health discuss the end of the COVID-19 Public Health Emergency.
A new study published in Proceedings of the National Academy of Sciences (PNAS) and led by University of Michigan School of Public Health researchers is adding to growing evidence of the association between cumulative malaria infections and endemic Burkitt lymphoma (eBL) in the sub-Saharan African countries of Uganda, Tanzania, and Kenya.
According to a new study published in the journal Clinical Infectious Diseases, while there have been major advances over the last decade in an effort to improve the effectiveness of seasonal influenza vaccine, innovative approaches are needed to significantly improve vaccine effectiveness. Study author Arnold Monto, professor of Epidemiology at the University of Michigan School of Public Health, discusses the findings.
For outstanding contributions to respiratory virus disease research over the course of his career, Dr. Arnold Monto, the Thomas Francis, Jr. Collegiate Professor of Public Health, has received the Lifetime Achievement Award from the International Society for Influenza and other Respiratory Virus Diseases (ISIRV).
A new COVID-19 booster shot for the Omricon variant will be made available. Aubree Gordon, associate professor of Epidemiology at the University of Michigan School of Public Health, describes the number of weeks it takes for anti-bodies from the booster shot to start working.
Long COVID was more prevalent among women, Hispanics and those with lower incomes, according to the most recent Michigan COVID-19 Recovery Surveillance Study report.